LGALS3 and cancer: G3-C12 is a Gal-3 binding peptide with an outstanding affinity (KD = 88 nM).255 Its i.v. administration significantly reduced metastatic cell deposition in several mice models.256 It is also being studied as targeting molecule to deliver peptide–polymer–drug conjugates to cancer cells.257–259